1th quarter of the year 2019, as at 31 March 2019, TCJ and its subsidiaries had the total revenue of Baht 289.69 million increased from Baht 277.73 million in the year 2018 or increased by 4.30
revenues slightly increased with no significant changes Cost of sales increased 4.69%, as a result of sales increased. Selling and administrative expenses decreased 2.2 3%, came from administrative
same period of 2019 showed a profit of Baht 444.48 million, increased loss of 104%. Besides, in 2019 the Group reversed the impairment loss of assets of Baht 486.70 million, remaining a net loss for the
OHTL Public Company Limited and its subsidiaries Management Discussion and Analysis for the first quarter ended 31 March 2018 (Unit: Thousand Baht) Quarter 1 2018 Quarter 1 2017 Increased/ (Decreased
(the “Company”) would like to clarify in operating performance for the 3rd quarter (three months period) ended September 30, 2017. The Company’s net profit was Baht 102.33 Million which increased Baht
increased . 1.2 Cost of hospital operations increased by Baht 33.70 million or 7.89% mainly due to the Medical personal expenses also increased because of the expanding capacity of subsidiaries. 1.3 Selling
Director and Manager The Stock Exchange of Thailand The Company would like to report the Company’s operating result for the year ended December 31, 2017 that total revenue was THB84.90 million increased by
period of 2018, increased by Baht 17.57 million or 22.7 percent as a result from increase in sale and the improvement of the inventory cost management as well as sales mix management in each product
% increased. The increment was in accordance with company’s expanding strategy and well management in marketing and sales; therefore, company’s revenues were able to growth better than overall of the industry
-wide MEG spreads, driven by increased capacity in Asia as well as lower MEG prices. The 2019 performance was exacerbated by an unplanned shutdown, which contributed to its $38M EBITDA decline. However